Impact of blood pressure levels within first 24 hours after mechanical thrombectomy on clinical outcome in acute ischemic stroke patients.


Journal

Journal of neurointerventional surgery
ISSN: 1759-8486
Titre abrégé: J Neurointerv Surg
Pays: England
ID NLM: 101517079

Informations de publication

Date de publication:
Aug 2019
Historique:
received: 08 11 2018
revised: 12 12 2018
accepted: 17 12 2018
pubmed: 8 2 2019
medline: 31 10 2019
entrez: 8 2 2019
Statut: ppublish

Résumé

Despite early management and technical success of mechanical thrombectomy (MT) for acute ischemic stroke (AIS), not all patients reach a good clinical outcome. Different factors may have an impact and we aimed to evaluate blood pressure (BP) levels in the first 24 hours after MT. Consecutive AIS patients treated with MT were enrolled in the retrospective bi-center study. Neurological deficit was assessed with National Institutes of Health Stroke Scale (NIHSS) and functional outcome after 3 months with modified Rankin scale (mRS) with a score 0-2 for good outcome. The presence of symptomatic intracerebral hemorrhage (SICH) was assessed according to the SITS-MOST criteria. Of 703 treated patients, completed BP levels were collected in 690 patients (350 males, mean age 71±13 years) with median of admission NIHSS 17 points. Patients with mRS 0-2 had a lower median of systolic BP (SBP) compared with those with poor outcome (131 vs 140 mm Hg, P<0.0001). The rate of SICH did not differ between the patients with a median of SBP <140 mm Hg and ≥140 mm Hg. (5.1% vs 5.1%, P=0.980). Multivariate regression analysis with adjustment for potential confounders showed a median of distolic BP (P=0.024, OR: 0.977, 95% CI: 0.957 to 0.997) as a predictor of good functional outcome after MT, and a median of maximal SBP (P=0.038; OR: 0.990, 95% CI: 0.981 to 0.999) in the patients with achieved recanalization. Lowering of BP within the first 24 hours after MT may have a positive impact on clinical outcome in treated patients.

Identifiants

pubmed: 30728203
pii: neurintsurg-2018-014548
doi: 10.1136/neurintsurg-2018-014548
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

735-739

Informations de copyright

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

David Cernik (D)

Department of Neurology, Krajska zdravotni as Masarykova nemocnice v Usti nad Labem oz, Usti nad Labem, Czech Republic.

Daniel Sanak (D)

Department of Neurology, Univ Hosp Olomouc, Olomouc, Czech Republic.

Petra Divisova (P)

Department of Neurology, Univ Hosp Olomouc, Olomouc, Czech Republic.

Martin Kocher (M)

Department of Radiology, Univ Hosp Olomouc, Olomouc, Czech Republic.

Filip Cihlar (F)

Department of Radiology, Krajska zdravotni as Masarykova nemocnice v Usti nad Labem oz, Usti nad Labem, Czech Republic.

Jana Zapletalova (J)

Department of Biometry and Statistics, Palacký University Medical School, Olomouc, Czech Republic.

Tomas Veverka (T)

Department of Neurology, Univ Hosp Olomouc, Olomouc, Czech Republic.

Andrea Prcuchova (A)

Department of Neurology, Krajska zdravotni as Masarykova nemocnice v Usti nad Labem oz, Usti nad Labem, Czech Republic.

Dusan Ospalik (D)

Department of Neurology, Krajska zdravotni as Masarykova nemocnice v Usti nad Labem oz, Usti nad Labem, Czech Republic.

Marie Cerna (M)

Department of Radiology, Univ Hosp Olomouc, Olomouc, Czech Republic.

Petra Janousova (P)

Department of Neurology, Univ Hosp Olomouc, Olomouc, Czech Republic.

Michal Kral (M)

Department of Neurology, Univ Hosp Olomouc, Olomouc, Czech Republic.

Tomas Dornak (T)

Department of Neurology, Univ Hosp Olomouc, Olomouc, Czech Republic.

Vojtech Prasil (V)

Department of Radiology, Univ Hosp Olomouc, Olomouc, Czech Republic.

David Franc (D)

Department of Neurology, Univ Hosp Olomouc, Olomouc, Czech Republic.

Petr Kanovsky (P)

Department of Neurology, Univ Hosp Olomouc, Olomouc, Czech Republic.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH